Condition
Advanced Esophageal Cancers|Primary Small Cell Lung Cancers|Non-Small-Cell Lung Carcinoma|Pleural Mesotheliomas|Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
Estimated Enrollment: 34
Age Group: 18 Years to 65 Years (Adult)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment
Study ID Numbers: 020205|02-C-0205
Study First Received: May 21, 2002
Last Updated: April 19, 2017
Estimated Primary Completion Date: October 8, 2008
Primary Outcome Measures:
Pharmacokinetics and toxicity profile
Sponsors and Collaborators:
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Website Link: https://ClinicalTrials.gov/show/NCT00037817
